ARINGHIERI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 162
EU - Europa 105
AS - Asia 39
AF - Africa 11
SA - Sud America 6
Totale 323
Nazione #
US - Stati Uniti d'America 158
IT - Italia 66
CN - Cina 21
SE - Svezia 17
SG - Singapore 12
CI - Costa d'Avorio 8
DE - Germania 6
GB - Regno Unito 6
BR - Brasile 5
BG - Bulgaria 4
SN - Senegal 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
MX - Messico 2
RU - Federazione Russa 2
VN - Vietnam 2
BE - Belgio 1
CA - Canada 1
FI - Finlandia 1
JP - Giappone 1
PA - Panama 1
TR - Turchia 1
VE - Venezuela 1
Totale 323
Città #
Chandler 25
Serra 20
Santa Clara 19
Fairfield 15
Ashburn 10
Woodbridge 9
Abidjan 8
Pisa 8
Seattle 8
Shanghai 8
Cambridge 7
Singapore 7
New York 6
Beijing 4
Boardman 4
Florence 4
Houston 4
Ogden 4
Rome 4
Sofia 4
Ann Arbor 3
Dakar 3
Lancaster 3
Lawrence 3
Princeton 3
Rimini 3
Wilmington 3
Bremen 2
Brno 2
Dong Ket 2
Frankfurt am Main 2
Genova 2
Hong Kong 2
London 2
Norwalk 2
Pietrasanta 2
Quanzhou 2
San Diego 2
Adana 1
Bragança Paulista 1
Brussels 1
Camacan 1
Casalfiumanese 1
Cupertino 1
Dalmine 1
Empoli 1
Esslingen am Neckar 1
Fuzhou 1
Jiaxing 1
Linyi 1
Lucca 1
Maracay 1
Milan 1
Montanhas 1
Ottawa 1
Panama City 1
Porto Alegre 1
Redmond 1
San Francisco 1
Santana do Seridó 1
Shenzhen 1
Totale 244
Nome #
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism 150
Is adult hippocampal neurogenesis really relevant for the treatment of psychiatric disorders? 97
Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences 58
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib 29
Totale 334
Categoria #
all - tutte 1.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 2 2 2 3 0
2020/202138 1 0 0 16 4 1 2 0 5 1 4 4
2021/202240 0 0 0 0 2 8 4 3 9 6 3 5
2022/202373 9 10 3 6 8 7 0 5 20 0 4 1
2023/202440 4 1 3 2 4 5 1 1 3 0 7 9
2024/202572 3 4 7 6 12 21 16 3 0 0 0 0
Totale 334